Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 250 of 431 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/01/18
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 10/31/02
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 12/31/06
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 10/10/17
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 12/20/18
Due: 12/20/19
Phase: N/A
Priority: Normal
Start: 10/10/22
End: 11/01/29
Due: 11/01/30
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 11/18/24
Due: 11/18/25
Phase: N/A
Priority: Normal
Start: 05/13/22
End: 11/01/25
Due: 11/01/26
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 11/02/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 07/31/10
Due: 07/31/11
Phase: N/A
Priority: Normal
Start: 06/13/17
End: 07/27/18
Due: 07/27/19
Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 09/30/07
Due: 09/30/08
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 11/30/07
Due: 11/30/08
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 04/15/25
End: 06/15/25
Due: 06/15/26
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 03/30/24
Due: 03/30/25
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 05/31/22
Due: 05/31/23